STERIS Q3 fiscal 2026 revenue rose 9% to $1.5 billion; EPS $1.96, outlook maintained
STERIS reported fiscal 2026 third-quarter results for the quarter ended December 31, 2025, with revenue up 9% to $1.5 billion and diluted EPS from continuing operations of $1.96, compared with $1.75 a year earlier. The company kept its fiscal 2026 adjusted EPS outlook of $10.15 to $10.30, but raised its estimate of the tariff hit to pre-tax profit to approximately $55 million from approximately $45 million.
Key points
- Q3 revenue from continuing operations was $1,496.2 million, up from $1,370.6 million; constant currency organic growth was 8%.
- Q3 diluted EPS from continuing operations was $1.96 versus $1.75; adjusted EPS was $2.53 versus $2.32.
- Fiscal 2026 outlook was maintained: adjusted EPS of $10.15 to $10.30 and revenue growth of 8% to 9%.
- Estimated tariff impact on pre-tax profit rose to approximately $55 million from approximately $45 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.